Results 61 to 70 of about 353,915 (269)
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Products of Normal Supersolvable Subgroups [PDF]
It is shown in this paper that if G is a finite group which is the product of two normal supersolvable subgroups of relatively prime index, then G is supersolvable.
openaire +1 more source
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
On intuitionistic fuzzy characteristic and Frattini subgroups [PDF]
This paper presents intuitionistic fuzzy characteristic subgroups and discusses some of its properties. It is established that an intuitionistic fuzzy subgroup of an intuitionistic fuzzy group is characteristic provided its cuts are characteristic ...
Paul Augustine Ejegwa +1 more
doaj +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Finite group with some c#-normal and S-quasinormally embedded subgroups
Let pp be a prime that divides the order of a finite group GG, and let PP be a Sylow pp-subgroup of GG. Assume that dd is the smallest number of generators of PP and define ℳd(P)={P1,P2,…,Pd}{{\mathcal{ {\mathcal M} }}}_{d}\left(P)=\left\{{P}_{1},{P}_{2},
Li Ning, Jiang Jing, Liu Jianjun
doaj +1 more source
Gaussian Measure of Normal Subgroups
Let $(\mu_t)_{t>0}$ be a Gaussian semigroup on a metric, separable, complete group $G$. If $H$ is a Borel measurable normal subgroup of $G$ such that $\mu_t(H) > 0$ for all $t$, then $\mu_t(H) = 1$ for every $t$. If, in addition, $\mu_t$ are symmetric, then $\mu_t(H) > 0$ for a single $t$ implies $\mu_t(H) = 1$ for all $t$.
Byczkowski, T., Hulanicki, A.
openaire +3 more sources
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
PERFECTLY STABLE AND NORMAL SUBGROUPS
The equivalence between the concepts of normal and perfectly stable subgroups is shown. The proof of the main theorem is based on a novel concept of hypergroups over a group.
openaire +2 more sources
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source

